Filing Details

Accession Number:
0001384101-19-000096
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-11 17:02:08
Reporting Period:
2019-07-10
Accepted Time:
2019-07-11 17:02:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588970 H Bonnie Anderson 6000 Shoreline Court
Suite 300
South San Francisco CA 94080
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-10 8,000 $2.68 127,955 No 4 M Direct
Common Stock Disposition 2019-07-10 7,853 $28.78 120,102 No 4 S Direct
Common Stock Disposition 2019-07-10 147 $29.41 119,955 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-07-10 8,000 $0.00 8,000 $2.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,500 2022-03-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 99,085 Indirect The Bonnie H. Anderson Living Trust
Footnotes
  1. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 22, 2018.
  2. Represents weighted average sales price. Sale prices for the transactions range from $28.40 to $29.39. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  3. Represents weighted average sales price. Sale prices for the transactions range from $29.40 to $29.44. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  4. The option is fully vested.